Chart Speaks - $DRREDDY

Dr. Reddy's Laboratories is trading in a strong long-term uptrend, supported by its position above the 50-week, 100-week and 200-week moving averages. The stock has recently bounced from the 50-week SMA and closed near ₹1,350, indicating renewed buying interest. The long-term structure remains constructive as higher highs and higher lows are intact despite the ongoing consolidation. Technically, the stock is approaching a descending trendline resistance connecting the previous swing highs around ₹1,360-1,380. A decisive weekly close above this zone would confirm a breakout from the consolidation pattern and could trigger fresh momentum towards ₹1,420, followed by ₹1,500. Rising volumes on the breakout would further strengthen the bullish case. On the downside, ₹1,265-1,250 remains the first support zone, coinciding with the 50-week and 100-week moving averages. This is likely to attract buying on declines. The 200-week SMA near ₹1,160 acts as a strong long-term support, keeping the primary trend positive. A sustained break below ₹1,250 may lead to short-term weakness towards ₹1,200, but the broader bullish structure would remain intact as long as the stock holds above the 200-week average. Overall, Dr. Reddy's is showing signs of accumulation after an extended consolidation. Traders should watch the ₹1,360-1,380 resistance zone closely, as a breakout could mark the beginning of the next leg of the uptrend. Until then, the stock is expected to remain range-bound with a positive long-term bias. $DRREDDY